echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Netflix AstraZeneca wants to buy Gilead or create largest biopharmaceutical merger

    Netflix AstraZeneca wants to buy Gilead or create largest biopharmaceutical merger

    • Last Update: 2020-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On the afternoon of June 7, AstraZeneca was in contact with Gilead Sciences about a possible merger that, if successful, would be the largest medical deal in history, involving $96 billion, according to people familiar with the matterif the merger succeeds, it will surpass the $74 billion merger between The Xerox and Newfoundation in 2019 and the $63 billion merger between AbbVie and AlKit is understood that AstraZeneca contacted Gilead last month for possible cooperationPeople familiar with the matter added that while Gilead had discussed the idea with financial advisers, it had not yet been decided and the two companies had not held formal talks
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.